Keep up to Date and Stay Informed

Sign up for email alerts to receive company updates including press releases, filings and special announcements straight to your inbox.

Sign me up for:

Latest Annual Filing

Fiscal Year Ended Dec 31, 2017

View Filing

Stock Information

Company Overview

Viveve, Inc., the wholly owned subsidiary of Viveve Medical, Inc., is a women's intimate health company based in Englewood, Colorado. The company is focused on the commercialization of a revolutionary, non-surgical, non-ablative medical device that remodels collagen and restores vaginal tissue. The Viveve® System, that delivers the Viveve treatment, incorporates clinically-proven, cryogen-cooled, monopolar radiofrequency (CMRF) energy to uniformly deliver deep- penetrating volumetric heat while gently cooling surface tissue to generate robust neocollagenesis in a single in-office session.

In the United States, the Viveve System is cleared by the FDA for general surgical procedures for electrocoagulation and hemostasis. International regulatory approvals and clearances have been received for vaginal laxity and/or improvement in sexual function indications in over 50 countries. Consistent with these approvals, in the second quarter of 2018, Viveve initiated VIVEVE II, a multicenter, randomized, double-blind, sham-controlled study to assess improvement of sexual function in women following childbirth following an Investigational Device Exemption (IDE) application approval from the U.S. Food and Drug Administration (FDA) in March of 2018. If successful, this trial could support a marketing application for a new U.S. commercial indication.

Viveve has initiated LIBERATE-International, one of two planned independent, multicenter, randomized registration trials for the improvement of stress urinary incontinence in women and has submitted an IDE to the FDA for LIBERATE-U.S. The results of these two studies, if successful, could support marketing applications in the U.S, and additional countries around the world for this new commercial indication.

Investor Presentation

Investor Presentation

Download Investor Presentation

Leadership

Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information

Company

Viveve Medical, Inc.
345 Inverness Drive South
Building B, Suite 250
Englewood, CO 80112
T: 720-696-8100
F: 720-696-8199
ir@viveve.com

Investor Relations

Stern Investor Relations, Inc.
1270 Avenue of the Americas
Suite 408
New York, NY 10020
T: (212) 362-1200
Sarah@sternir.com

Amato and Partners
90 Park Avenue, 17th Floor
New York, NY 10016
T: (212) 430-0360
Admin@amatoandpartners.com

Transfer Agent

VStock Transfer, LLC
Patricia Sumoza
Account Administrator - Team Supervisor
18 Lafayette Place
Woodmere, NY 11598
T: (212) 828-8436
F: (646) 536-3179
www.VStockTransfer.com